Parenteral formulations of gemcitabine derivatives

Details for Australian Patent Application No. 2010322516 (hide)

Owner Clavis Pharma AS

Inventors Ahrabi, Sayeh; Myhren, Finn; Eriksen, Ole Henrik

Agent Davies Collison Cave

Pub. Number AU-A-2010322516

PCT Pub. Number WO2011/062503

Priority 61/262,999 20.11.09 US

Filing date 15 November 2010

Wipo publication date 26 May 2011

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/7068 (2006.01)

A61K 9/133 (2006.01) Medicinal preparations characterised by special physical form - Unilamellar vesicles

A61P 35/00 (2006.01) Antineoplastic agents

C07H 19/06 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

17 May 2012 PCT application entered the National Phase

  PCT publication WO2011/062503 Priority application(s): WO2011/062503

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010322517-Cutting device, method and use for cutting of a line extending from a floating vessel

2010322478-Benzoimidazole compounds and uses thereof